RGNT
Regentis Biomaterials Ltd
3월 13일 10:34 AM ET (한국 3/13 23:34)
$3.28
+0.17 ▲ +5.31%
| Index | - | P/E | - | EPS (ttm) | -2.67 | Insider Own | 50.26% | Shs Outstand | 0.00B | Perf Week | -2.53% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -30.32% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 11.15% | Short Float | 1.05% | Perf Quarter | -53.87% |
| Income | -0.01B | P/S | - | EPS this Y | 97.19% | Inst Trans | 30.54% | Short Ratio | 1.24 | Perf Half Y | - |
| Sales | 0.00B | P/B | 3.58 | EPS next 5Y | - | ROA | -336.99% | Short Interest | 0.03M | Perf YTD | -51.41% |
| Book/sh | 0.92 | P/C | 2.3 | EPS past 3/5Y | 11.45% -71.58% | ROE | - | 52W High | -60.78% ($8.35) | Perf Year | - |
| Cash/sh | 1.42 | P/FCF | - | Sales past 3/5Y | - | ROIC | -288.13% | 52W Low | 5.65% ($3.10) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -376.99% | Gross Margin | - | Volatility(W/M) | 0.99% 6.9% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.32 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.65 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 31.77 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.65 | Sales Q/Q | - | SMA20 | -11.28% ($3.7) | Beta | - | Target Price | $10 |
| Payout | - | Debt/Eq | 0.25 | Earnings | - | SMA50 | -37.92% ($5.28) | Rel Volume | 0.09 | Prev Close | $3.11 |
| Employees | 10 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -42.13% ($5.67) | Avg Volume(3M) | 0.02M | Price | $3.28 |
| IPO | 2025/12/4 | Option/Short | No/Yes | Trades | 1485 | Volume | 1,937 | Change | 5.31% |
뉴스 로딩 중...